| 发明名称 |
Treatment of Depressive Disorders |
| 摘要 |
Pregn-4-en-20-yn-3β-one is useful in the treatment of depressive disorders by nasal administration. |
| 申请公布号 |
US2014187524(A1) |
申请公布日期 |
2014.07.03 |
| 申请号 |
US201314134906 |
申请日期 |
2013.12.19 |
| 申请人 |
PHERIN PHARMACEUTICALS, INC. |
发明人 |
MONTI LOUIS |
| 分类号 |
A61K31/57;A61K45/06 |
主分类号 |
A61K31/57 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a depressive disorder in an individual suffering therefrom, comprising nasal administration of a therapeutically effective amount of pregn-4-en-20-yn-3-one. |
| 地址 |
LOS ALTOS CA US |
